Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 3 | Journal of Ophthalmic Inflammation and Infection

Fig. 3

From: Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Fig. 3

Among 12 patients who received a single 0.2 μg/day FAc  intravitreal implant, 5 (42%) did not experience a recurrence of either uveitis or cystic macular oedema during the follow-up period of between 36 and 80 months. Black lines indicate clinic visits, blue lines indicate recurrence of cystoid macular oedema, red lines indicate recurrence of uveitis

Back to article page